Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Surgery Partners (SGRY) Non-Current Debt (2016 - 2025)

Historic Non-Current Debt for Surgery Partners (SGRY) over the last 12 years, with Q3 2025 value amounting to $3.5 billion.

  • Surgery Partners' Non-Current Debt rose 1184.15% to $3.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $3.5 billion, marking a year-over-year increase of 1184.15%. This contributed to the annual value of $3.3 billion for FY2024, which is 2098.97% up from last year.
  • According to the latest figures from Q3 2025, Surgery Partners' Non-Current Debt is $3.5 billion, which was up 1184.15% from $3.5 billion recorded in Q2 2025.
  • In the past 5 years, Surgery Partners' Non-Current Debt ranged from a high of $3.5 billion in Q2 2025 and a low of $2.5 billion during Q2 2023
  • Its 5-year average for Non-Current Debt is $2.9 billion, with a median of $2.9 billion in 2021.
  • As far as peak fluctuations go, Surgery Partners' Non-Current Debt tumbled by 1704.31% in 2023, and later surged by 2337.68% in 2025.
  • Surgery Partners' Non-Current Debt (Quarter) stood at $2.9 billion in 2021, then decreased by 11.1% to $2.6 billion in 2022, then rose by 5.58% to $2.7 billion in 2023, then increased by 20.99% to $3.3 billion in 2024, then increased by 5.86% to $3.5 billion in 2025.
  • Its Non-Current Debt stands at $3.5 billion for Q3 2025, versus $3.5 billion for Q2 2025 and $3.4 billion for Q1 2025.